SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 37.31 |
Enterprise Value ($M) | 35.78 |
Book Value ($M) | 2.47 |
Book Value / Share | 0.08 |
Price / Book | 15.10 |
NCAV ($M) | 2.37 |
NCAV / Share | 0.08 |
Price / NCAV | 15.76 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.77 |
Return on Assets (ROA) | -0.46 |
Return on Equity (ROE) | -1.29 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 4.01 |
Current Ratio | 4.01 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 9.83 |
Assets | 9.93 |
Liabilities | 7.46 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 3.50 |
Operating Income | -5.88 |
Net Income | -5.81 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -3.97 |
Cash from Investing | -1.88 |
Cash from Financing | 5.85 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Francisco Trust under agreement dated February 28, 1996 | 11.52 | -3.89 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
Form 10-K for the year ended December 31, 2024 | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
3,406 | 13,963 | 24.39 | |
3,100 | 71,460 | 4.34 | |
982 | 4,194 | 23.41 | |
(click for more detail) |
Similar Companies | |
---|---|
DRUG – Bright Minds Biosciences Inc. | DTIL – Precision BioSciences, Inc. |
DWTX – Dogwood Therapeutics, Inc. | EDSA – Edesa Biotech, Inc. |
ELDN – Eledon Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io